A double blind Placebo Controlled randomised Trial of Adalimumab in the treatment of Hidradenitis Suppurativa
British Journal of Dermatology, 04/04/2011
Exclusive author commentary
Miller I et al. – A significant reduction was seen in Sartorius after 6 weeks and an almost significant reduction was seen after 12 weeks of active treatment when compared to the placebo–group. Significant reduction in Hidradenitis Suppurativa severity was gained after 6 weeks. No long–term curative effect was uniformly seen.
I. Miller (04/12/2011) comments:
In this pilot randomised clinical trial we present further evidence supporting the efficacy of TNF alpha blockage in hidradenitis suppurativa